Xtant Medical (NYSE:XTNT) said that CEO Dan Goldberger resigned effective Jan. 21 “to pursue other interests.” The Belgrade, Mont.-based company, which was formed after Bacterin paid $86 million for spinal implant maker X-Spine Systems, said president Carl O’Connell will step in as interim CEO while the company’s board “contemplates the permanent CEO,” according to a […]
Misonix (NSDQ:MSON) today saw shares rise slightly despite saying it will miss the filing deadline for its quarterly report due to an ongoing investigation, according to an SEC filing posted today. The filing follows a delayed annual report from the company that came through in June, Misonix said, due to an investigation from the audit committee […]
Misonix (NSDQ:MSON) said today its interim CEO Stavros Vizirgianakis invested $4 million into the company through the purchase of 761,469 shares at $5.25 per share. The shares purchased are considered to be “restricted shares,” as they were acquired in a transaction not involving a public offering. The shares, therefore, cannot be sold without appropriate registration under […]
Misonix CEO steps down Misonix (NSDQ:MSON) CEO Michael McManus, Jr. stepped down in early September, also leaving his post as director and chairman of the board of directors. Stavros Vizirgianakis, a member of the board of directors, is serving as the interim CEO while negotiating for a full-time position in the corner office. Vizirgiankis, who owned […]
Misonix (NSDQ:MSON) this week reached out to the Securities and Exchange Commission and the U.S. Department of Justice over possible issues with the Chinese distributor of its products, according to an SEC filing posted today. The company said that on Sept. 27 and Sept. 28, respectively, it contacted the SEC and DOJ to “voluntarily inform” them that […]
Misonix (NSDQ:MSON) said today that it delayed its annual report due to “deficiencies” in its internal financial reporting controls and posted a swing to red ink for fiscal 2016. The Farmingdale, N.Y.-based company also said it named Joseph Dwyer as interim CFO, replacing Richard Zaremba, who was named senior finance VP. “The filing stated that the audit committee […]
The spinal med device market appears to be stabilizing with growth in 3 key areas, according to a letter to investors published this week from Leerink Partner’s Richard Newitter, who attended the North American Spine Society’s annual meeting in Chicago last week. Newitter said the meeting was “neutral-to-positive” for firms in the spinal market, and said […]
The Limerick, Pa.-based medical device company said its "preliminary financial goals" for 2013 are for sales growth of 11%-13% and adjusted EPS of $4.70-$4.90.